Skip to main content
El País English

El País English

Newspaper | Spain | Centre-Left

Engagement Insights

9
Discussions
0
Participants
0
Total Votes
329
Articles

Discussions from El País English

Politics

What are the possible effects of democratic socialism on policies in Washington D.C.?

The triumph of a democratic socialist in the D.C. mayoral race is the latest sign that younger urban voters are turbo-charging candidates who promise to go big on affordability and take on President Trump. Why it matters: While Washington joined New York and Seattle as the latest big city to elect a democratic socialist, Janeese Lewis George's victory was less about her political label than about punishing prices and anger at the president. State of play: Lewis George, who handily defeated a moderate in the Democratic primary, marks a break from decades of business-friendly politicians running the nation's capital. Three trends explain her rise: Unhappiness with the city's direction stood at the highest level (55%) since Marion Barry's reign 28 years ago, per a Washington Post-Schar School poll. A lot of that disaffection was driven by Trump, but there was also a shout for change after three terms of Mayor Muriel Bowser.Washington's influx of white residents, who tend to be younger and more progressive, made winning that vote even more important, and Lewis George ran up the score in neighborhoods where they've settled. She also proved critics wrong by winning in majority-Black, working-class communities — the only place she lost was the city's wealthiest enclave, Northwest's Ward 3. Nearly half of D.C.'s registered Democrats have a favorable view of socialism, per the poll — so it's not a turnoff. Three other progressives led D.C. Council races, giving the presumptive mayor powerful allies. Zoom in: Lewis George appears to have broken through by: Echoing New York City Mayor Zohran Mamdani, she made the cost of living her No. 1 issue. Her rival, Kenyan McDuffie, ran on public safety and called her soft on crime, even as violence was fading as a top issue. Assembling a potent get-out-the-vote machine that encompassed almost every major local union plus the Democratic Socialists of America's local chapter, which helped knock on what she says were 200,000 doors.Crafting

United States
Politics

How should funding for ICE be decided when there are different views on related programs?

$72 billion in funding for ICE and Border Patrol is now in limbo after GOP senators revolted against President Trump's $1.776B "anti-weaponization fund" on Thursday. Why it matters: The fund was dropped like "a bomb in the middle of a pretty well planned out reconciliation bill," Sen. Lisa Murkowski (R-Alaska) told reporters. Zoom in: The package for ICE and Border Patrol funding was on track to pass by the weekend. But senators left town without voting on Thursday after a heated two-hour meeting with acting Attorney General Todd Blanche."[T]hey need to help with this issue, because we have a lot of members who are concerned," Senate Majority Leader John Thune (R-S.D.) told Punchbowl News about the White House and the fund. "Somebody described it as a galactic blunder, and I think that's probably true," Sen. Ron Johnson (R-Wisc.) told CNN. Between the lines: The Senate spent the first few days of the week trying to decide what to do about the $1 billion for security upgrades related to the White House ballroom. As of Wednesday that funding had been stripped, Axios reported. But the Senate has yet to release text of the budget bill ahead of a vote-a-rama. The bottom line: I'm not sure the fund should exist," said Sen. Bill Cassidy, who lost his Louisiana GOP primary on Saturday as part of Trump's revenge tour

United States
Healthcare

How might the discovery of plasma biomarkers for Alzheimer's in middle-aged people affect health policies and community support programs?

Alzheimer's disease has a long preclinical phase in which neuropathological changes, such as amyloid β (Aβ) and tau pathology, accumulate over many years.1 This preclinical phase provides an opportunity for earlier disease detection and interventions to prevent or delay dementia. Emerging blood-based biomarkers provide a minimally invasive approach to assess Alzheimer's disease-related pathology and show promising diagnostic and prognostic value in symptomatic individuals.2 However, performance of these biomarkers in cognitively unimpaired, middle-aged populations remains unclear

Global